AbbVie Inc. (ABBV) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
AbbVie Inc. (ABBV) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (70% profit margin, 29% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
How ABBV Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $61.16B | 70.2% | 24.6% | $4.23B | $17.82B | 52.1% |
| FY 2024 | $56.33B | 70% | 16.2% | $4.28B | $17.83B | 24.5% |
| FY 2023 | $54.32B | 44% | 23.5% | $4.86B | $20.39B | 5.9% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring ABBV)
- ✓Live walkthrough of ABBV's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
ABBV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ABBV today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ABBV. Explore sector supply chains on /butterfly.
ABBV Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is AbbVie Inc. (ABBV)?
In FY 2025 (10-K), ABBV converted $61.2B of revenue into a 70.2% gross margin, 24.6% operating margin, and $17.8B in free cash flow (29.1% FCF margin).